Imaging Modalities of Gastrointestinal Stromal Tumors

被引：14

作者：

Choi, Haesun ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Unit 1473, Houston, TX 77030 USA

来源：

JOURNAL OF SURGICAL ONCOLOGY | 2011年 / 104卷 / 08期

关键词：

gastrointestinal stromal tumors; CT; FDG-PET; imaging; POSITRON-EMISSION-TOMOGRAPHY; IMATINIB MESYLATE; FDG-PET; RESPONSE EVALUATION; INHIBITOR STI571; CANCER-CELLS; C-KIT; THERAPY; DIAGNOSIS; GIST;

D O I：

10.1002/jso.21871

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Recent dramatic improvement of survival of Gastrointestinal stromal tumor patients alongside the development of a new targeted treatment has made the role of imaging increasingly more important not only in diagnosing the disease, but also in monitoring the treatment effect and surveillance. Computed tomography is currently the imaging modality of choice for these purposes. This article reviews the current roles of different imaging modalities in clinical management of the gastrointestinal stromal tumors. J. Surg. Oncol. 2011;104:907-914. (C) 2011 Wiley Periodicals, Inc.

引用

页码：907 / 914

页数：8

共 55 条

[1]

Antoch G, 2004, J NUCL MED, V45, P357

[2] We should desist using RECIST, at least in GIST [J].

Benjamin, Robert S. ;

Choi, Haesun ;

Macapinlac, Homer A. ;

Burgess, Michael A. ;

Patel, Shreyaskumar R. ;

Chen, Lei L. ;

Podoloff, Donald A. ;

Charnsangavej, Chuslip .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (13) :1760-1764

[3]

Berger F, 2007, 93 SCI ASS ANN M RAD, P534

[4]

Blanke C, 2004, P 2004 GASTR CANC S, P43

[5] Imaging of Gastrointestinal Stromal Tumors and Assessment of Benefit from SystemicTherapy [J].

Boonsirikamchai, Piyaporn ;

Podoloff, Donald A. ;

Choi, Haesun .

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2009, 23 (01) :35-+

[6] A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors [J].

Chen, LL ;

Trent, JC ;

Wu, EF ;

Fuller, GN ;

Ramdas, L ;

Zhang, W ;

Raymond, AK ;

Prieto, VG ;

Oyedeji, CO ;

Hunt, KK ;

Pollock, RE ;

Feig, BW ;

Hayes, KJ ;

Choi, H ;

Macapinlac, HA ;

Hittelman, W ;

Velasco, MA ;

Patel, S ;

Burgess, MA ;

Benjamin, RS ;

Frazier, ML .

CANCER RESEARCH, 2004, 64 (17) :5913-5919

[7] CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: A quantitative analysis correlated with FDG PET findings [J].

Choi, H ;

Charnsangavej, C ;

Faria, SD ;

Tamm, EP ;

Benjamin, RS ;

Johnson, MM ;

Macapinlac, HA ;

Podoloff, DA .

AMERICAN JOURNAL OF ROENTGENOLOGY, 2004, 183 (06) :1619-1628

[8] Response evaluation of gastrointestinal stromal tumors [J].

Choi, Haesun .

ONCOLOGIST, 2008, 13 :4-7

[9] Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: Proposal of new computed tomography response criteria [J].

Choi, Haesun ;

Charnsangavej, Chuslip ;

Faria, Silvana C. ;

Macapinlac, Homer A. ;

Burgess, Michael A. ;

Patel, Shreyaskumar R. ;

Chen, Lei L. ;

Podoloff, Donald A. ;

Benjamin, Robert S. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (13) :1753-1759

[10] The GIST of targeted cancer therapy:: A tumor (Gastrointestinal stromal tumor), a mutated gene (c-kit), and a molecular inhibitor (STI571) [J].

DeMatteo, RP .

ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (09) :831-839

← 1 2 3 4 5 6 →